Correlation Between AN2 Therapeutics and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Neoleukin Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Neoleukin Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Neoleukin Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between AN2 and Neoleukin is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Neoleukin Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.86 times more return on investment than Neoleukin Therapeutics. However, AN2 Therapeutics is 1.86 times more volatile than Neoleukin Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Neoleukin Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 560.00 in AN2 Therapeutics on August 29, 2024 and sell it today you would lose (421.00) from holding AN2 Therapeutics or give up 75.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 13.74% |
| Values | Daily Returns |
AN2 Therapeutics vs. Neoleukin Therapeutics
Performance |
| Timeline |
| AN2 Therapeutics |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AN2 Therapeutics and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Neoleukin Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals | AN2 Therapeutics vs. Seres Therapeutics |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |